NextCure Inc. (NXTC)
0.81
-0.00 (-0.31%)
At close: Jan 28, 2025, 1:51 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -62.72M | -74.73M | -69.39M | -36.60M | -33.74M | -22.80M | -15.47M |
| Depreciation & Amortization | 3.68M | 4.12M | 7.20M | 3.41M | 2.69M | 1.68M | 582.00K |
| Stock-Based Compensation | 8.19M | 9.51M | 10.29M | 7.91M | 1.89M | 263.00K | 75.00K |
| Other Working Capital | n/a | 1.40M | -3.38M | -21.71M | -5.84M | 27.51M | 1.53M |
| Other Non-Cash Items | -183.00K | 3.49M | 23.74M | 12.70M | 7.26M | 3.21M | 1.24M |
| Deferred Income Tax | n/a | n/a | -23.74M | -12.70M | -7.26M | n/a | n/a |
| Change in Working Capital | -1.94M | 3.73M | -5.34M | -19.68M | -6.46M | 28.85M | 2.30M |
| Operating Cash Flow | -52.97M | -53.89M | -57.24M | -44.95M | -35.62M | 7.99M | -12.51M |
| Capital Expenditures | -820.00K | -2.12M | -2.36M | -7.13M | -3.37M | -3.06M | -8.65M |
| Acquisitions | n/a | -70.09K | -38.96K | -50.66K | n/a | n/a | n/a |
| Purchase of Investments | -73.50M | -34.64M | -156.48M | -137.13M | -300.55M | n/a | n/a |
| Sales Maturities Of Investments | 113.60M | 104.74M | 195.44M | 187.78M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 70.09K | 38.96K | 50.66K | -300.55K | n/a | n/a |
| Investing Cash Flow | 39.27M | 67.98M | 36.60M | 43.52M | -303.92M | -3.06M | -8.65M |
| Debt Repayment | n/a | n/a | -3.47M | -1.53M | 4.54M | -400.00K | -140.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 154.00K | 200.00K | 208.00K | n/a | n/a | 121.81M | 25.00M |
| Financial Cash Flow | 154.00K | 200.00K | -3.27M | -1.42M | 243.04M | 121.42M | 24.86M |
| Net Cash Flow | -13.55M | 14.29M | -23.91M | -2.85M | -96.50M | 126.35M | 3.69M |
| Free Cash Flow | -53.79M | -56.00M | -59.60M | -52.09M | -38.99M | 4.93M | -21.17M |